Background and purpose Familial idiopathic basal ganglia calcification (FIBGC) is an autosomal dominant condition characterized by symmetric calcification in the basal ganglia and other brain regions. Here, we describe three novel causative mutations in SLC20A2 associated with FIBGC. Methods Three independent patients with clinical and neuroradiological findings compatible with FIBGC were analyzed for mutations in SLC20A2 gene. A detailed clinical and neuroradiological evaluation was performed. Results We identified the c.188 G>A (p.Gly63Asp) and c.1196 A>C (p.His399Pro) missense changes in two patients presenting with migraine without aura, and the c.187 G>A (p.Gly63Ser) in a man and his sister with bipolar disorder type 2 and cognitive impairment. Conclusions Our work further corroborates the extreme phenotypic variability in FIBGC patients, also when the same amino acid residue is mutated. We describe the first patient with a mutation in SLC20A2 and bipolar disorder type 2. Moreover, sequential CT scans in one case documented the progression of brain calcifications.

Three novel missense mutations in SLC20A2 associated with idiopathic basal ganglia calcification

RUBINO, Elisa;GIORGIO, ELISA;ZIBETTI, Maurizio;LOPIANO, Leonardo;FERRERO, Patrizia;DUCA, SERGIO;MORETTI, RICCARDO DIONIGI LUIGI;GALLONE, SALVATORE;RAINERO, Innocenzo;BRUSCO, Alfredo
2017

Abstract

Background and purpose Familial idiopathic basal ganglia calcification (FIBGC) is an autosomal dominant condition characterized by symmetric calcification in the basal ganglia and other brain regions. Here, we describe three novel causative mutations in SLC20A2 associated with FIBGC. Methods Three independent patients with clinical and neuroradiological findings compatible with FIBGC were analyzed for mutations in SLC20A2 gene. A detailed clinical and neuroradiological evaluation was performed. Results We identified the c.188 G>A (p.Gly63Asp) and c.1196 A>C (p.His399Pro) missense changes in two patients presenting with migraine without aura, and the c.187 G>A (p.Gly63Ser) in a man and his sister with bipolar disorder type 2 and cognitive impairment. Conclusions Our work further corroborates the extreme phenotypic variability in FIBGC patients, also when the same amino acid residue is mutated. We describe the first patient with a mutation in SLC20A2 and bipolar disorder type 2. Moreover, sequential CT scans in one case documented the progression of brain calcifications.
377
62
64
http://www.sciencedirect.com/science/article/pii/S0022510X17302228?via%3Dihub
Basal ganglia calcification; Bipolar disorder; Fahr's syndrome; Migraines; SLC20A2; Neurology; Neurology (clinical)
Rubino, E; Giorgio, E; Godani, M; Grosso, E; Zibetti, M; Lopiano, L; Ferrero, P; Duca, S; Moretti, L; Gallone, S; Rainero, I; Brusco, A.
File in questo prodotto:
File Dimensione Formato  
SLC20A2-all.pdf

Accesso aperto con embargo fino al 31/03/2018

Descrizione: Postprint finale
Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 1.72 MB
Formato Adobe PDF
1.72 MB Adobe PDF Visualizza/Apri
SLC20A2-JNS2017.pdf

Accesso riservato

Descrizione: Versione pubblicata
Tipo di file: PDF EDITORIALE
Dimensione 582.68 kB
Formato Adobe PDF
582.68 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2318/1650376
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 7
social impact